scispace - formally typeset
Z

Zabi Wardak

Researcher at University of Texas Southwestern Medical Center

Publications -  46
Citations -  1355

Zabi Wardak is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Radiation therapy & Medicine. The author has an hindex of 11, co-authored 33 publications receiving 906 citations. Previous affiliations of Zabi Wardak include State University of New York Upstate Medical University & Loma Linda University.

Papers
More filters
Journal ArticleDOI

Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.

TL;DR: Consolidative SAbR prior to maintenance chemotherapy appeared beneficial, nearly tripling PFS in patients with limited metastatic NSCLC compared with maintenance chemotherapy alone, with no difference in toxic effects.
Journal ArticleDOI

Phase II Trial of Stereotactic Body Radiation Therapy Combined With Erlotinib for Patients With Limited but Progressive Metastatic Non–Small-Cell Lung Cancer

TL;DR: Use of SBRT with erlotinib for unselected patients with stage IV NSCLC as a second- or subsequent line therapy resulted in dramatic changes in patterns of failure, was well tolerated, and resulted in high PFS and OS, substantially greater than historical values for patients who only received systemic agents.
Journal ArticleDOI

MRI-only brain radiotherapy: Assessing the dosimetric accuracy of synthetic CT images generated using a deep learning approach

TL;DR: The GAN model developed produced highly accurate synthetic CT images from conventional, single-sequence MRI images in seconds, and has strong potential to perform well in a clinical workflow for MRI-only brain treatment planning.
Journal ArticleDOI

Risk of venous thromboembolism in bone and soft‐tissue sarcoma patients undergoing surgical intervention: A report from prior to the initiation of SCIP measures

TL;DR: This study reviews incidence and risk factors for venous thromboembolism in bone/soft‐tissue sarcoma patients prior to the initiation of Surgical Care Improvement Program (SCIP) measures in October 2009.